| |
All-Cause Readmission at 30-Days Post-Discharge |
|
| |
Base Model |
Demographic Adjusted Model |
Caregiving Adjusted Model |
Clinical Condition Adjusted Model |
Fully Adjusted Model |
| |
OR (95%CI) |
OR (95%CI) |
OR (95%CI) |
OR (95%CI) |
OR (95%CI) |
| Race/Ethnicity |
|
| Black vs. White/Asian |
0.83 (0.29, 2.34) |
0.93 (0.32, 2.68) |
0.81 (0.29, 2.28) |
0.87 (0.30, 2.53) |
0.88 (0.30, 2.63) |
| Hispanic vs. White/Asian |
3.20 (1.58, 6.47) |
3.65 (1.73, 7.72) |
2.96 (1.45, 6.05) |
3.18 (1.52, 6.66) |
3.14 (1.43, 6.88) |
| Hispanic vs. Black |
3.85 (1.38, 10.77) |
3.93 (1.40, 11.03) |
3.67 (1.31, 10.31) |
3.65 (1.27, 10.49) |
3.55 (1.23, 10.27) |
| Age ≥65 |
- |
1.20 (0.61, 2.34) |
- |
- |
0.79 (0.37, 1.67) |
| Men |
- |
1.48 (0.72, 3.02) |
- |
- |
1.49 (0.70, 3.18) |
| Medicaid vs. Other/No Health Insurance Type |
- |
0.84 (0.34, 2.07) |
- |
- |
0.91 (0.36, 2.32) |
| Paid Caregiver Prior to Admit or Post Discharge vs. None |
- |
- |
1.74 (0.88, 3.44) |
- |
1.74 (0.83, 3.65) |
| Ischemic Heart Failure |
- |
- |
- |
1.23 (0.59, 2.57) |
1.22 (0.58, 2.58) |
| Hypertension |
- |
- |
- |
1.33 (0.59, 2.99) |
1.42 (0.61, 3.28) |
| Diabetes |
- |
- |
- |
1.40 (0.67, 2.92) |
1.35 (0.64, 2.83) |
| Renal Failure/Dialysis |
- |
- |
- |
1.52 (0.73, 3.15) |
1.48 (0.70, 3.13) |
| Peripheral Vascular Disease |
- |
- |
- |
1.87 (0.76, 4.59) |
1.88 (0.76, 4.63) |
| Inotrope |
- |
- |
- |
1.09 (0.48, 2.47) |
1.17 (0.51, 2.70) |
| Statin |
- |
- |
- |
1.25 (0.57, 2.76) |
1.27 (0.58, 2.81) |
| Ace/ARB |
- |
- |
- |
1.32 (0.64, 2.74) |
1.37 (0.65, 2.85) |
| Beta Blocker |
- |
- |
- |
0.65 (0.30, 1.41) |
0.64 (0.29, 1.42) |
| Calcium Channel Blocker |
- |
- |
- |
0.75 (0.29, 1.93) |
0.72 (0.27, 1.92) |
| Diuretic |
- |
- |
- |
0.86 (0.37, 2.01) |
0.81 (0.34, 1.91) |
|
